Electric shocks and chemo aim to stop pancreatic Cancer's return
NCT ID NCT04281290
First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This early-phase study tests whether using electric pulses to deliver chemotherapy (bleomycin) directly to the surgical site can lower the chance of pancreatic cancer returning after surgery. About 10 to 20 adults with removable pancreatic tumors will receive this treatment. The main goals are to check safety and see if it helps keep cancer away longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Medical Centre Ljubljana, Ljubljana, Slovenia
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.